Stockscreener 앱 받기
9.59
1.80%
0.17
시간 외 거래:
9.58
-0.010
-0.10%
Intellia Therapeutics Inc 주식(NTLA)의 최신 뉴스
Is Intellia Therapeutics Inc 38I a good long term investmentExit Strategy Tips & Download Our Free Trading Blueprint - earlytimes.in
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Will Intellia Therapeutics Inc. stock remain a Wall Street favoriteTrade Ideas & Long-Term Growth Plans - ulpravda.ru
Will Intellia Therapeutics Inc. stock continue dividend increasesJuly 2025 Momentum & Stepwise Trade Signal Implementation - DonanımHaber
Will Intellia Therapeutics Inc. (38I) stock hit analyst forecastsJuly 2025 Retail & Weekly High Momentum Picks - DonanımHaber
Is Intellia Therapeutics Inc. stock a top momentum play2025 Stock Rankings & Accurate Buy Signal Alerts - DonanımHaber
Will Intellia Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - Улправда
Intellia Therapeutics (NTLA) Receives a Buy from Leerink Partners - The Globe and Mail
623,600 Shares in Intellia Therapeutics, Inc. $NTLA Acquired by Marex Group plc - MarketBeat
Intellia Therapeutics, Inc. $NTLA Shares Sold by Nikko Asset Management Americas Inc. - MarketBeat
Intellia Therapeutics CEO Sells Shares Under Trading Plan - TradingView — Track All Markets
Intellia Therapeutics, Inc. $NTLA Shares Purchased by Armistice Capital LLC - MarketBeat
(NTLA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
JPMorgan Chase & Co. Purchases 396,858 Shares of Intellia Therapeutics, Inc. $NTLA - MarketBeat
Volume Recap: Will Intellia Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Action & Free Weekly Watchlist of Top Performers - moha.gov.vn
Intellia Therapeutics (NASDAQ:NTLA) Nasdaq Index Expands Genetic Research - Kalkine Media
Intellia Therapeutics (NASDAQ:NTLA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Why Intellia Therapeutics (NTLA) Is Up 6.9% After Disclosing Serious Liver Safety Events In Lead CRISPR Trials - Sahm
Would You Still Hold Intellia Therapeutics Stock If It Fell Another 30%? - Trefis
Investors who Lost Money on Intellia Therapeutics, Inc. (NTLA) Should Contact Levi & Korsinsky About Pending Class ActionNTLA - 28/22 News
Schroder Investment Management Group Increases Stock Holdings in Intellia Therapeutics, Inc. $NTLA - MarketBeat
Intellia Focuses on Pipeline Development Amid Stiff Competition - MSN
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Will Intellia Therapeutics Inc. (38I) stock benefit from mergersJuly 2025 Momentum & Weekly Stock Performance Updates - Newser
How analysts revise price targets for Intellia Therapeutics Inc. (38I) stockWeekly Risk Report & Accurate Technical Buy Alerts - Newser
Intellia Therapeutics (NASDAQ: NTLA) issues 12,600 inducement RSUs to three new employees - Stock Titan
Will Intellia Therapeutics Inc. (38I) stock recover faster than industryMarket Volume Summary & Technical Pattern Alert System - Newser
What dividend safety rating applies to Intellia Therapeutics Inc. (38I) stockMarket Sentiment Report & AI Based Trade Execution Alerts - Newser
Why analysts maintain buy rating on Intellia Therapeutics Inc. (38I) stockJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory - Finviz
Intellia Therapeutics (NASDAQ:NTLA) Stock Price Up 7.1%Should You Buy? - MarketBeat
Does Intellia Therapeutics Inc. (38I) stock trade below intrinsic valueQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - Newser
Is Intellia Therapeutics Inc. stock attractive for growth ETFs2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
Why Intellia Therapeutics Inc. (38I) stock remains top ratedWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
What is the fair value estimate for Intellia Therapeutics Inc. (38I) stock in 2025Trend Reversal & Accurate Entry/Exit Alerts - Newser
Will Intellia Therapeutics Inc. (38I) stock outperform value peersJuly 2025 Summary & Technical Pattern Based Buy Signals - Newser
Will Intellia Therapeutics Inc. (38I) stock profit from AI boomMarket Activity Summary & Capital Protection Trade Alerts - Newser
Intellia Therapeutics: Critical Safety Updates Are ImminentExpect Volatility (NTLA) - Seeking Alpha
Is Intellia Therapeutics Inc. (38I) stock nearing a technical breakout2025 Price Targets & Weekly High Momentum Picks - Newser
Can Intellia Therapeutics Inc. (38I) stock survive global slowdown - Newser
Intellia Q3 Loss Narrower Than Expected, Stock Down on Pipeline Trouble - MSN
Intellia Therapeutics (NASDAQ:NTLA) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Geode Capital Management LLC Boosts Holdings in Intellia Therapeutics, Inc. $NTLA - MarketBeat
Can Intellia Therapeutics (NTLA) Rebuild Trust Amid Safety Setbacks and Regulatory Challenges? - Sahm
How (NTLA) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Intellia Therapeutics (NTLA): Valuation Insights After NTLA-2001 Safety Setback and Analyst Downgrade - Yahoo Finance
Intellia Therapeutics, Inc. $NTLA Shares Sold by Orchard Capital Management LLC - MarketBeat
Pullback Watch: Will Intellia Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Weekly Recap & Intraday High Probability Alerts - moha.gov.vn
0.36%
0.21%
자본화:
|
볼륨(24시간):